A 26 year-old man with suspected Cushing's disease underwent transsphenoidal exploration of the pituitary without any evidence of microadenoma or hyperplasia.
ECTOPIC ACTH syndrome is recognized with increasing frequency, but still poses diagnostic and therapeutic problems. Although the treatment of choice is surgical removal of the ACTH-producing tumor, the source of ectopic ACTH production often remains undetermined in patients with occult tumor [1 , 2] . In such a situation, the approach is to control hypercortisolism by medical or surgical adrenalectomy until the ACTH-producing tumor becomes evident and resectable.
However, the tumor may become nonresectable at the time of diagnosis, thus concerted effort to determine the site of ectopic ACTH production is warranted. Since the majority of these tumors arise from the thorax (lung and [1, 3] , the presence of a thymic mass in suspected ectopic ACTH syndrome is a matter of great concern. However, benign thymic hyperplasia has been reported to occur after correction of hypercortisolism in patients with ectopic ACTH syndrome [4-6].
Pro-opiomelanocortin (POMC), a precursor of ACTH and j3-endorphin, is primarily synthesized in the pituitary gland, but its transcripts and ACTHrelated peptides are detected in some tumors not associated with ectopic ACTH syndrome and even in normal tissues as well [7] . Lymphocytes derived from the peripheral blood and spleen have been demonstrated to express POMC gene and produce a limited amount of ACTH and p-endorphin [8] [9] [10] . However, no report is yet available as to whether lymphocytes can serve as a source of ectopic ACTH production and cause excess hypercortisolism. We describe herein a patient with Cushing's syndrome in whom lymphocytes in thymic hyperplasia were con- (Table 1) . Although oral administration of high-dose (8 mg) dexamethasone failed to suppress urinary 17-OHCS excretion more than 50% of the baseline levels, intravenous infusion of dexamethasone (5 mg) suppressed plasma cortisol levels from 39.4 to 19.0 ag/dl. Oral administration of metyrapone (3 g) increased urinary 17-OHCS excretion from 52.2 to 98.7 mg/day. Intravenous administration of human corticotropin-releasing hormone (100 rig) caused elevation of plasma levels of ACTH and cortisol (Table  1) . CT scan and magnetic resonance imaging (MRI) of the brain gave no evidence of pituitary tumor. Neither CT scan nor ultrasonography revealed any abnormal mass in the abdomen, lung or mediastinum, except for bilateral adrenal enlargement. All efforts to determine the possible source of ectopic ACTH production were nondiagnostic. Inferior petrosus sinus sampling was not performed due to unskillful technique. Because of the most probable diagnosis of Cushing's disease, the patient had surgical exploration of the pituitary gland via transsphenoidal approach in November, 1990; neither microadenoma nor corticotroph hyperplasia was identified, but Crooke cells were present in the adenohypophysis. Despite partial hypophysectomy, his hypercortisolism persisted which could not be alleviated with medical treatment with metyrapone (2-3 g/day) and mitotane (3 g/day).
Bilateral adrenalectomy was performed in July 1991, which resulted in complete remission of Cushing's syndrome. He was on maintenance dose of hydrocorti- (Fig. 1) . A thymic mass (10 x 9 cm size) was resected in June 1992. Microscopical examination revealed well-encapsulated benign thymic hyperplasia with well-maintained cortico-medullary boundary; no epithelial or carcinoid tumor cells were demonstrated ( Fig. 2A) . Postoperative plasma ACTH levels fell to 14 pg/ml. One mg oral dexamethazone suppressed ACTH to less than the detectable limit and the patient restored normal diurnal ACTH rhythm. Combined stimulation with insulin, LH-RH and TRH showed improved peak response of TSH, but blunted responses of GH, LH and FSH. Hyperpigmentation of skin gradually disappeared. During 8 year-follow-up interval, he has been in good health and repeated ACTH determinations were normal (10-20 pg/ml). CT of the thorax before and after bilateral adrenalectomy.
(A) No thymic mass visible within the anterior mediastinum.
(B) A distinct anterior mediastinal mass 9 months after bilateral adrenalectomy. 
In situ hybridization
Methods with cDNA probes for human POMC gene (1.9 kb) labeled with a-[32P]-dCTP using the random-priming method.
In situ hybridization was performed using a digoxygenin-UTP cRNA specific to the exon 3 of POMC gene on paraffin-embedded sections (4 um) of the surgically removed thymic tissue. Radioimmunoassay and gel permeation chromatography ACTH concentration in the sample was measured by radioimmunoassay using the antibody against Nterminal fragment of ACTH [11] . In brief, 0.1 ml sample and 0.1 ml antibody (final dilution, l : 50,000) were preincubated at 4°C for 24 hrs, followed by the addition of 0.1 ml [125I] ACTH (specific activity: 2000 Ci/mmol, Amersham Japan) and further incubation for 24 hrs. The bound ligands were separated from free by a double antibody method. The limit of detection of ACTH was 5 pg/ml; inter-and intraassay coefficients of variation were 10.5 and 5.0%, respectively. Gel permeation chromatography was performed using Sephadex-50 column (Pharmacia, Uppsala, Sweden) as described [12] .
Northern blot analysis
We prepared poly (A)+ RNAs by the guanidinium thiocyanate method.
We hybridized northern blots
Results
In situ hybridization confirmed the expression of pro-opiomelanocortin (POMC) transcripts in normal lymphocytes of the excised thymus (Fig. 2B) , which disappeared after RNase treatment (Fig. 2C) . The excised thymic tissue extracts contained high concentration of ACTH-like immunoreactivity (98 pg/g tissue) as determined by radioimmunoassay. Gel chromatographic analysis of the thymic tissue extract revealed a major peak corresponding to human ACTH(1-39) and a yet unspecified minor peak (M.W.2700) (Fig. 3) . Northern hybridization of poly (A)+ RNA extracted from thymic tissue using human POMC cDNA as a probe revealed a band corresponding to the size (1.2 kb) of POMC mRNA (Fig. 4) .
Discussion
Dramatic enlargement of the thymus is reported to occur as early as 3-4 weeks following remission of hypercortisolism after removal of the tumors or treatment with steroidgenesis inhibitors [4, 6], which spontaneously regressed or persisted for as long as Gel chromatography using Sephadex G50 column (1 x 50 cm) of thymic tissue extract. was eluted at the position corresponding to the size of human ACTH (1-39).
A major component of ACTH ]. The precise mechanism of thymic hyperplasia remains unknown, but a `rebound' phenomenon is plausible. It has been demonstrated that glucocorticoids induce a striking reduction in size of the thymus [13] , and the glucocorticoid-induced thymic atrophy can be followed by regrowth of the thymus to a larger size (`rebound' enlargement) than the original after drug withdrawal [14] . These observations were consistent with our case since thymic enlargement occurred only after a dramatic decline in cortisol levels by total adrenalectomy.
On the basis of these reports, physicians have been alerted to avert a diagnostic thymectomy especially when thymic appearance suggests benign hyperplasia.
In the present patient, however, benign thymic hyperplasia was most likely to be the source of ectopic ACTH production by five lines of evidence: (1) 10, 17] . This should provide a rationale for normal thymic lymphocytes as a possible site of ectopic ACTH production in the event of deregulated transcriptional states. The thymic lymphocytes of the present patient showed a distinct band of POMC mRNA which had a similar size (1.2 kb) to that of the pituitary transcripts as revealed by Northern blotting, while gel chromatographic analysis revealed the presence of a small molecular weight form (M.W. 2700) in addition to a major peak corresponding to human ACTH(1-39). These results suggest a possible altered processing of POMC transcripts in the patient's thymic tissue. This case reinforces the difficulties involved in diagnosis of occult ectopic ACTH-producing tumors, and demonstrates that hyperplastic, but apparently normal, thymic tissue could be the source of ectopic ACTH production.
Physicians must also be aware of this other possibility to "rebound" thymic hyperplasia [4] whenever diagnostic thymectomy is indicated. 
